A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis.

作者: AM Attallah , MS Albannan , MM Omran , R Zayed , S Saif

DOI: 10.1080/09674845.2019.1600325

关键词: AlbuminHepatitis C virusHepatic fibrosisGastroenterologyMedicineLiver function testsPlatelet-derived growth factor receptorHepatic stellate cellInternal medicineBiomarker (medicine)Fibrosis

摘要: Background: Several studies have investigated certain fibrosis markers that incorporate liver function tests, fragments of liver-matrix components and/or degraded products generated by hepatic stellate cells for determining the degree fibrosis. However, role these molecules in development is unclear. This work aimed (a) to determine whether platelet-derived growth factor (PDGF) linked different stages and (b) investigate its diagnostic performance alongside other laboratory demographic factors assessing chronic hepatitis C infection. Methods: Liver-fibrosis was staged according Fibroscan, PDGF quantified using ELISA, tests analytes determined standard techniques 239 patients with virus Results: Patients significant (F2-F4), advanced (F3-F4) cirrhotic disease (F4) showed significantly (P<0.0001) higher levels increase respectively compared stage F0/1. We used this construct PARA-Index (PDGF/albumin ratio, age), which performed well hepatic-fibrosis AUCs 0.91, 0.87 0.86 identifying F2-F4, F3-F4 F4, respectively. Additionally, correlated strongly (r=0.65, P<0.0001) severity An elevated PARA-index provided odds ratios 21.0, 20.7 10.3 developing Conclusion: A panel mitogenic (PDGF), biochemical (albumin) demographical (age) parameters may improve liver-fibrosis staging a high accuracy those

参考文章(36)
MICHAEL JP ARTHUR, DEREK A MANN, JOHN P IREDALE, Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis. Journal of Gastroenterology and Hepatology. ,vol. 13, ,(1998) , 10.1111/JGH.1998.13.S1.33
Kamfai Lee, Kuo-Liang Wei, Chien-Heng Shen, I-Lin Lee, Te-Sheng Chang, Yi-Hsiung Lin, Chia-Sheng Chuang, Yung-Yu Hsieh, Shui-Yi Tung, Cheng-Shyong Wu, FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis. Chang Gung medical journal. ,vol. 32, pp. 614- 622 ,(2009)
Giada Sebastiani, Alfredo Alberti, Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy World Journal of Gastroenterology. ,vol. 12, pp. 3682- 3694 ,(2006) , 10.3748/WJG.V12.I23.3682
M. Pinzani, A. Caligiuri, R. Defranco, H. Herbst, R. G. Romanelli, S. Milani, G. Pellegrini, P. Gentilini, A. Gentilini, C. Grappone, Dac Vinh Ngo, Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. American Journal of Pathology. ,vol. 148, pp. 785- 800 ,(1996)
Eman Medhat, Hosny Salama, Hanan Fouad, Hanan Abd El Haleem, Mohamad Said, Saeed M. El-Nahaas, Dalia Omran, Serum Soluble CD14 in Egyptian Patients with Chronic Hepatitis C: Its Relationship to Disease Progression and Response to Treatment. Journal of Interferon and Cytokine Research. ,vol. 35, pp. 563- 568 ,(2015) , 10.1089/JIR.2014.0155
Mario Plebani, Daniela Basso, Non-invasive assessment of chronic liver and gastric diseases Clinica Chimica Acta. ,vol. 381, pp. 39- 49 ,(2007) , 10.1016/J.CCA.2007.02.019
T. W. Evans, Review article: albumin as a drug—biological effects of albumin unrelated to oncotic pressure Alimentary Pharmacology & Therapeutics. ,vol. 16, pp. 6- 11 ,(2002) , 10.1046/J.1365-2036.16.S5.2.X
Albert Farrugia, Albumin usage in clinical medicine: tradition or therapeutic? Transfusion Medicine Reviews. ,vol. 24, pp. 53- 63 ,(2010) , 10.1016/J.TMRV.2009.09.005
Chun-Tao Wai, Joel K Greenson, Robert J Fontana, John D Kalbfleisch, Jorge A Marrero, Hari S Conjeevaram, Anna S-F Lok, None, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology. ,vol. 38, pp. 518- 526 ,(2003) , 10.1053/JHEP.2003.50346